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Dear Editor, 
Blood donations saves the lives of millions of people 
worldwide, and blood transfusion is essential to the effec-
tiveness of the health care system by supporting modern 
medicine as its pivotal role in patient interventions (1, 
2). new, more sophisticated medical and surgical proce-
dures such as transplant, heart surgery, and trauma or 
cancer treatment depend highly  on blood transfusions 
in each country. Moreover, blood samples improve the 
quality of life of multitransfused patients.  In developing 
countries transfusion-transmitted infections (TTIs) often 
threaten the safety of patients requiring blood transfu-
sion, and medical providers face serious challenges with 
blood availability, safety, and affordability. It is estimated 
that 45% of the 80 million blood donations across the 
globe are collected each year in developing countries 
that comprised roughly 80% of the world’s population 
(3, 4). 
on a national level, countries should secure the safety 
of patients requiring blood transfusion by creating stan-
dard blood-transfusion establishments with solid sup-
port from policy makers and adequate and consistent 
government funding. one of the most prominent factors 
in ensuring safe blood samples is to have a national pro-
gram for donor selection, recruitment, retention, and ed-
ucation to minimize donations from donors who might 
transmit diseases to recipients (2, 4). In addition, to en-
sure blood safety it is important to monitor and evaluate 
TTIs, including hepatitis B virus (HBV) and hepatitis C vi-
rus (HCV), among blood donors and in the general popu-
lation. The prevalence of transfusion transmitted infec-
tions among blood donors in well-structured health care 
system with a well-organized blood establishment can 
be used as a reliable tool for statistical estimations of 
those infectious agent that can be transmitted through 
blood products including Hepatitis B and C. Indeed, the 
prevalence size of HCV or HBV among blood donors in 
such countries can contribute to statistical estimation 
of those viruses in the general population (5). In Petro-
vic’s study, the prevalence rates of chronic HBV and HCV 
in the general populations of the Tuzla Canton in Bosnia 
and Herzegovina have been estimated by the adjusted 
prevalence of HBs-Ag and anti-HCV seropositive samples 
among first-time blood donors.  In the current study 
the statistical analysis of prevalence rates has been per-
formed based on incidence calculation of the estimated 
ratio between the two populations (the first-time blood 
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donors and general population) using Poisson distribu-
tion method through reviewing published papers (6). 
However, epidemiological studies of HBV and HCV in 
general  populations  have  faced  difficulties  in  obtain-
ing  sufficient  sample  sizes,  gender  and  age  distribu-
tions, and financial support. nevertheless, the process of 
blood-donor selection aims to identify and recruit nonre-
munerated, apparently healthy people willing to donate 
blood.  The donated blood should be free of bloodborne 
infectious agents that can be transmitted to recipients, 
and this depends highly on the structure of the country’s 
health care system (6, 7). In addition, blood-transfusion 
establishments should meet the international require-
ments for standard operating procedures that play a piv-
otal role in protecting the safety of both donors and re-
cipients. Especially after the AIDS epidemic, the concern 
about blood safety in multitransfused patients has in-
creased greatly. As the authors have explained, recruited 
blood donors are usually healthier because they are from 
people in the community who tend to exhibit healthier 
behaviors and safer life styles (8). 
In conclusion, the accuracy of estimating TTI preva-
lence in the general population by surveying first-time 
blood donors depends on how similar the demograph-
ic characteristics of the two populations are. What we 
perceive  from  this  study  are  significant  differences  in 
TTI  prevalence  rates  between  first-time  and  regular 
blood donors (data not shown here but available upon 
request), particularly in terms of demographic charac-
teristics (e.g., cultural-economic issues), the structure of 
regional or country health care systems, blood transfu-
sion service structures, blood donation incentives, blood 
type of donors (paid-donors, family replacement donors, 
or volunteer nonremunerated blood donors). Indeed, it 
seems that the populations of the countries or regions 
in which the reviewed studies were conducted are not 
demographically compatible or similar enough for valid 
inferences to be made.
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